Stay updated on IMGN779 in CD33+ AML: Clinical Trial

Sign up to get notified when there's something new on the IMGN779 in CD33+ AML: Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the IMGN779 in CD33+ AML: Clinical Trial page

  1. Check
    10 days ago
    No Change Detected
  2. Check
    17 days ago
    Change Detected
    Summary
    Site revision updated to v3.4.3 and v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-06T18:52:36.000Z thumbnail image
  3. Check
    24 days ago
    Change Detected
    Summary
    No additions or deletions are visible; the page content appears unchanged between the two screenshots.
    Difference
    0.1%
    Check dated 2026-02-27T19:01:27.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Page revision updated from v3.4.1 to v3.4.2; no visible changes to study details or layout. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-02-13T12:47:49.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision tag updated from v3.4.0 to v3.4.1. This is a minor page update and does not affect the study details presented on the page.
    Difference
    0.1%
    Check dated 2026-02-05T19:08:00.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Revision tag updated to v3.3.4 on the page, replacing the previous v3.3.3.
    Difference
    0.1%
    Check dated 2026-01-15T03:26:10.000Z thumbnail image
  7. Check
    89 days ago
    Change Detected
    Summary
    Locations section reorganized: a unified 'Locations' section was added and state-specific location headings were removed. The revision updated from v3.3.2 to v3.3.3.
    Difference
    0.8%
    Check dated 2025-12-24T15:41:51.000Z thumbnail image

Stay in the know with updates to IMGN779 in CD33+ AML: Clinical Trial

Enter your email address, and we'll notify you when there's something new on the IMGN779 in CD33+ AML: Clinical Trial page.